Cello Group PLC | Cash Flow

Fiscal year is January-December. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
5,459.00
3,790.00
4,754.00
1,686.00
5,817.00
8,419
Depreciation, Depletion & Amortization
2,561.00
2,464.00
2,008.00
1,965.00
2,216.00
2,074
Other Funds
1,066.00
742.00
1,179.00
1,072.00
2,599.00
257
Funds from Operations
6,954.00
6,996.00
7,941.00
1,351.00
5,434.00
10,236
Changes in Working Capital
1,895.00
5,049.00
1,236.00
3,255.00
3,069.00
596
Net Operating Cash Flow
8,849.00
1,947.00
6,705.00
4,606.00
2,365.00
10,832
Capital Expenditures
1,359.00
1,477.00
1,180.00
2,276.00
1,871.00
Sale of Fixed Assets & Businesses
27.00
29.00
16.00
30.00
30.00
Net Investing Cash Flow
2,109.00
2,997.00
1,364.00
2,271.00
7,100.00
Cash Dividends Paid - Total
1,643.00
2,559.00
2,244.00
2,596.00
3,575.00
Issuance/Reduction of Debt, Net
3,124.00
2,691.00
3,694.00
1,727.00
212.00
Net Financing Cash Flow
4,772.00
462.00
5,821.00
580.00
10,601.00
Net Change in Cash
1,836.00
418.00
317.00
2,217.00
5,555.00
Free Cash Flow
7,802.00
844.00
5,891.00
2,640.00
903.00
Net Assets from Acquisitions
777.00
1,549.00
200.00
25.00
5,259.00
Change in Capital Stock
5.00
330.00
117.00
289.00
14,388.00
Exchange Rate Effect
132.00
170.00
163.00
462.00
311.00

About Cello Group

View Profile
Address
11-13 Charterhouse Buildings
London London & South East EC1M 7AP
United Kingdom
Employees -
Website http://cellogroup.co.uk
Updated 07/08/2019
Cello Health Plc is a global insight and strategic marketing group with a primary focus on the pharmaceutical and health sectors. It operates through two segments: Cello Health and Cello signal. The Cello Health segment provides market research, consulting, and communications services principally to its pharmaceutical and healthcare clients.